<p>Vest Financial LLC 在最近向美国证券交易委员会提交的 13F 表格中表示，其在 Elevance Health, Inc. (NYSE:ELV - 免费报告) 的持股在第三季度减少了 10.8%。该基金在此期间出售了 10,817 股后，持有该公司 88,982 股股票。Vest Financial LLC 在 Elevance Health 的持股在最近的报告期末价值为 28,752,000 美元。</p>
<ul>
<li>这个 ETF 证明了医疗保健反弹是真实的</li>
</ul>
<p>其他几家对冲基金和机构投资者最近也买卖了该公司的股票。Joel Isaacson &amp; Co. LLC 在第三季度将其在 Elevance Health 的股份增加了 45.3%。Joel Isaacson &amp; Co. LLC 现在拥有 1,765 股该公司的股票，价值 570,000 美元，此前在上个季度又购买了 550 股。Sage Mountain Advisors LLC 在第三季度将其在 Elevance Health 的持股增加了 18.2%。Sage Mountain Advisors LLC 现在拥有 1,848 股该公司的股票，价值 597,000 美元，此前在上个季度又收购了 285 股。Jackson Thornton Wealth Management LLC 在第三季度购买了 Elevance Health 的新头寸，价值 256,000 美元。Americana Partners LLC 在第三季度获得了 Elevance Health 的新头寸，价值 393,000 美元。最后，Professional Advisory Services Inc. 在第三季度将其在 Elevance Health 的股份增加了 1.6%。Professional Advisory Services Inc. 现在拥有 76,354 股该公司的股票，价值 24,672,000 美元，此前在上个季度又购买了 1,170 股。目前，89.24% 的股票由对冲基金和其他机构投资者持有。</p>
<p>获取 <strong>Elevance Health</strong> 的提醒：</p>
<h2>华尔街分析师预测增长</h2>
<p>几位股票分析师最近对该股票发表了评论。Sanford C. Bernstein 在 1 月 6 日的研究报告中重申了 “跑赢大盘” 的评级，并设定了 Elevance Health 股票的目标价为 431.00 美元。Robert W. Baird 将 Elevance Health 的目标价从 297.00 美元上调至 340.00 美元，并在 12 月 11 日的报告中给予该股票 “中性” 评级。Mizuho 在 1 月 9 日的报告中设定了 Elevance Health 的目标价为 413.00 美元。美国银行在 10 月 10 日的研究报告中将 Elevance Health 的目标价从 330.00 美元上调至 370.00 美元，并给予该公司 “中性” 评级。最后，富国银行在 1 月 7 日的报告中将 Elevance Health 股票的目标价从 403.00 美元上调至 424.00 美元，并给予该股票 “超配” 评级。十三位分析师对该股票给予了买入评级，十二位分析师对该公司的股票给予了持有评级。根据 MarketBeat 的数据，该公司目前的平均评级为 “适度买入”，平均目标价为 400.85 美元。</p>
<ul>
<li>防御性投资：3 家支付股息的公司报告强劲的第三季度收益</li>
</ul>
<p><strong>查看我们对 Elevance Health 的最新分析</strong></p>
<h2>Elevance Health 价格表现</h2>
<p>NYSE ELV 的股票在周三开盘价为 368.27 美元。Elevance Health, Inc. 的 1 年低点为 273.71 美元，1 年高点为 458.75 美元。该公司的市值为 818.4 亿美元，市盈率为 15.05，市盈率/增长比率为 1.93，贝塔系数为 0.51。该公司的债务与股本比率为 0.71，流动比率为 1.56，速动比率为 1.56。该公司的 50 日移动平均价格为 346.57 美元，200 日移动平均价格为 328.18 美元。</p>
<ul>
<li>为什么 Centene 股票下跌了 40% — 现在是否值得买入</li>
</ul>
<p>Elevance Health (NYSE:ELV - 获取免费报告) 最近在 10 月 21 日发布了季度收益数据。该公司报告本季度每股收益为 6.03 美元，超出分析师一致预期的 5.03 美元，超出 1.00 美元。该公司的季度收入为 500.9 亿美元，而分析师预期为 492.6 亿美元。Elevance Health 的净利润率为 2.84%，股本回报率为 16.17%。该公司的季度收入较去年同期增长了 12.0%。去年同期，该公司每股收益为 8.37 美元。研究分析师预计 Elevance Health, Inc. 本年度将发布 33.96 美元的每股收益。</p>
<h2>Elevance Health 简介</h2>
<p>(免费报告)</p>
<p>Elevance Health, Inc NYSE: ELV 是一家总部位于美国的大型健康福利公司，提供广泛的健康保险产品和相关服务。公司总部位于印第安纳波利斯，2022 年从 Anthem, Inc 更名为 Elevance Health，同时继续以既有的州和国家品牌运营面向消费者的健康计划。Gail Boudreaux 担任首席执行官和总裁，领导公司在综合医疗和福利交付方面的战略重点。</p>
<p>Elevance 的核心业务包括为个人、雇主和政府项目（包括 Medicare 和 Medicaid 管理医疗产品）提供医疗和专业健康计划。</p>
<h2>精选文章</h2>
<ul>
<li>五只我们更看好的股票，胜过 Elevance Health</li>
<li>Elon 正在将 SpaceX 上市！$100 的 IPO 前机会！</li>
<li>家族信托如何帮助保护您的财富</li>
<li>请勿删除，立即阅读</li>
<li>美国 “出生权” 索赔价值数万亿 - 静悄悄地激活</li>
<li>执行命令 14330：特朗普迄今为止最大的一次</li>
</ul>
<p><strong>想看看其他对冲基金持有的 ELV 吗？</strong> 访问 HoldingsChannel.com 获取 Elevance Health, Inc. (NYSE:ELV - 免费报告) 的最新 13F 文件和内部交易。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUVMVg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUVMVg"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>您现在应该投资 1,000 美元在 Elevance Health 吗？</h2>
<p>在您考虑 Elevance Health 之前，您需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及他们推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Elevance Health 并不在名单上。</p>
<p>虽然 Elevance Health 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

医疗业 ETF - SPDR

美国医疗保健供应商 ETF - iShares

医疗业 ETF - Vanguard

<p>Vest Financial LLC 在第三季度减少了对 Elevance Health, Inc. (NYSE:ELV) 的持股，减幅为 10.8%，目前持有 88,982 股，出售了 10,817 股。这些持股的价值约为 2875 万美元。其他机构投资者也调整了他们的头寸，其中 Joel Isaacson & Co. LLC 和 Sage Mountain Advisors LLC 的增持尤为显著。分析师对 Elevance Health 维持 “适度买入” 的评级，平均目标价为 400.85 美元。该股票开盘价为 368.27 美元，市值为 818.4 亿美元，市盈率为 15.05</p>

<p>Vest Financial LLC lowered its holdings in Elevance Health, Inc. (NYSE:ELV - Free Report) by 10.8% in the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 88,982 shares of the company's stock after selling 10,817 shares during the period. Vest Financial LLC's holdings in Elevance Health were worth $28,752,000 at the end of the most recent reporting period.</p>
<div class="lb-trans"><p>Vest Financial LLC 在最近向美国证券交易委员会提交的 13F 表格中表示，其在 Elevance Health, Inc. (NYSE:ELV - 免费报告) 的持股在第三季度减少了 10.8%。该基金在此期间出售了 10,817 股后，持有该公司 88,982 股股票。Vest Financial LLC 在 Elevance Health 的持股在最近的报告期末价值为 28,752,000 美元。</p>
</div><ul>
<li>This ETF Is Proof That the Healthcare Rebound Is Real</li>
</ul>
<div class="lb-trans"><ul>
<li>这个 ETF 证明了医疗保健反弹是真实的</li>
</ul>
</div><p>Several other hedge funds and other institutional investors also recently bought and sold shares of the business. Joel Isaacson &amp; Co. LLC boosted its stake in shares of Elevance Health by 45.3% during the 3rd quarter. Joel Isaacson &amp; Co. LLC now owns 1,765 shares of the company's stock valued at $570,000 after buying an additional 550 shares during the last quarter. Sage Mountain Advisors LLC raised its holdings in Elevance Health by 18.2% in the third quarter. Sage Mountain Advisors LLC now owns 1,848 shares of the company's stock valued at $597,000 after acquiring an additional 285 shares in the last quarter. Jackson Thornton Wealth Management LLC bought a new position in Elevance Health during the 3rd quarter valued at $256,000. Americana Partners LLC acquired a new position in Elevance Health during the 3rd quarter worth $393,000. Finally, Professional Advisory Services Inc. increased its position in shares of Elevance Health by 1.6% in the 3rd quarter. Professional Advisory Services Inc. now owns 76,354 shares of the company's stock worth $24,672,000 after purchasing an additional 1,170 shares during the last quarter. 89.24% of the stock is currently owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>其他几家对冲基金和机构投资者最近也买卖了该公司的股票。Joel Isaacson &amp; Co. LLC 在第三季度将其在 Elevance Health 的股份增加了 45.3%。Joel Isaacson &amp; Co. LLC 现在拥有 1,765 股该公司的股票，价值 570,000 美元，此前在上个季度又购买了 550 股。Sage Mountain Advisors LLC 在第三季度将其在 Elevance Health 的持股增加了 18.2%。Sage Mountain Advisors LLC 现在拥有 1,848 股该公司的股票，价值 597,000 美元，此前在上个季度又收购了 285 股。Jackson Thornton Wealth Management LLC 在第三季度购买了 Elevance Health 的新头寸，价值 256,000 美元。Americana Partners LLC 在第三季度获得了 Elevance Health 的新头寸，价值 393,000 美元。最后，Professional Advisory Services Inc. 在第三季度将其在 Elevance Health 的股份增加了 1.6%。Professional Advisory Services Inc. 现在拥有 76,354 股该公司的股票，价值 24,672,000 美元，此前在上个季度又购买了 1,170 股。目前，89.24% 的股票由对冲基金和其他机构投资者持有。</p>
</div><p>Get <strong>Elevance Health</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Elevance Health</strong> 的提醒：</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>华尔街分析师预测增长</h2>
</div><p>Several equities analysts have recently commented on the stock. Sanford C. Bernstein reaffirmed an &#34;outperform&#34; rating and set a $431.00 price target on shares of Elevance Health in a research report on Tuesday, January 6th. Robert W. Baird increased their target price on Elevance Health from $297.00 to $340.00 and gave the stock a &#34;neutral&#34; rating in a report on Thursday, December 11th. Mizuho set a $413.00 price target on Elevance Health in a report on Friday, January 9th. Bank of America upped their price target on Elevance Health from $330.00 to $370.00 and gave the company a &#34;neutral&#34; rating in a research report on Friday, October 10th. Finally, Wells Fargo &amp; Company lifted their price objective on shares of Elevance Health from $403.00 to $424.00 and gave the stock an &#34;overweight&#34; rating in a report on Wednesday, January 7th. Thirteen analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of &#34;Moderate Buy&#34; and an average target price of $400.85.</p>
<div class="lb-trans"><p>几位股票分析师最近对该股票发表了评论。Sanford C. Bernstein 在 1 月 6 日的研究报告中重申了 “跑赢大盘” 的评级，并设定了 Elevance Health 股票的目标价为 431.00 美元。Robert W. Baird 将 Elevance Health 的目标价从 297.00 美元上调至 340.00 美元，并在 12 月 11 日的报告中给予该股票 “中性” 评级。Mizuho 在 1 月 9 日的报告中设定了 Elevance Health 的目标价为 413.00 美元。美国银行在 10 月 10 日的研究报告中将 Elevance Health 的目标价从 330.00 美元上调至 370.00 美元，并给予该公司 “中性” 评级。最后，富国银行在 1 月 7 日的报告中将 Elevance Health 股票的目标价从 403.00 美元上调至 424.00 美元，并给予该股票 “超配” 评级。十三位分析师对该股票给予了买入评级，十二位分析师对该公司的股票给予了持有评级。根据 MarketBeat 的数据，该公司目前的平均评级为 “适度买入”，平均目标价为 400.85 美元。</p>
</div><ul>
<li>Getting Defensive: 3 Dividend Payers Reporting Strong Q3 Earnings</li>
</ul>
<div class="lb-trans"><ul>
<li>防御性投资：3 家支付股息的公司报告强劲的第三季度收益</li>
</ul>
</div><p><strong>View Our Latest Analysis on Elevance Health</strong></p>
<div class="lb-trans"><p><strong>查看我们对 Elevance Health 的最新分析</strong></p>
</div><h2>Elevance Health Price Performance</h2>
<div class="lb-trans"><h2>Elevance Health 价格表现</h2>
</div><p>Shares of NYSE ELV opened at $368.27 on Wednesday. Elevance Health, Inc. has a 1-year low of $273.71 and a 1-year high of $458.75. The firm has a market capitalization of $81.84 billion, a PE ratio of 15.05, a P/E/G ratio of 1.93 and a beta of 0.51. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.56 and a quick ratio of 1.56. The business's fifty day moving average price is $346.57 and its two-hundred day moving average price is $328.18.</p>
<div class="lb-trans"><p>NYSE ELV 的股票在周三开盘价为 368.27 美元。Elevance Health, Inc. 的 1 年低点为 273.71 美元，1 年高点为 458.75 美元。该公司的市值为 818.4 亿美元，市盈率为 15.05，市盈率/增长比率为 1.93，贝塔系数为 0.51。该公司的债务与股本比率为 0.71，流动比率为 1.56，速动比率为 1.56。该公司的 50 日移动平均价格为 346.57 美元，200 日移动平均价格为 328.18 美元。</p>
</div><ul>
<li>Why Centene Stock Dropped 40% — And Whether It's a Buy Now</li>
</ul>
<div class="lb-trans"><ul>
<li>为什么 Centene 股票下跌了 40% — 现在是否值得买入</li>
</ul>
</div><p>Elevance Health (NYSE:ELV - Get Free Report) last released its quarterly earnings data on Tuesday, October 21st. The company reported $6.03 earnings per share for the quarter, topping analysts' consensus estimates of $5.03 by $1.00. The business had revenue of $50.09 billion for the quarter, compared to analysts' expectations of $49.26 billion. Elevance Health had a net margin of 2.84% and a return on equity of 16.17%. The company's revenue for the quarter was up 12.0% compared to the same quarter last year. During the same quarter last year, the company earned $8.37 EPS. On average, research analysts expect that Elevance Health, Inc. will post 33.96 EPS for the current year.</p>
<div class="lb-trans"><p>Elevance Health (NYSE:ELV - 获取免费报告) 最近在 10 月 21 日发布了季度收益数据。该公司报告本季度每股收益为 6.03 美元，超出分析师一致预期的 5.03 美元，超出 1.00 美元。该公司的季度收入为 500.9 亿美元，而分析师预期为 492.6 亿美元。Elevance Health 的净利润率为 2.84%，股本回报率为 16.17%。该公司的季度收入较去年同期增长了 12.0%。去年同期，该公司每股收益为 8.37 美元。研究分析师预计 Elevance Health, Inc. 本年度将发布 33.96 美元的每股收益。</p>
</div><h2>Elevance Health Profile</h2>
<div class="lb-trans"><h2>Elevance Health 简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免费报告)</p>
</div><p>Elevance Health, Inc NYSE: ELV is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company's strategic focus on integrated health care and benefit delivery.</p>
<div class="lb-trans"><p>Elevance Health, Inc NYSE: ELV 是一家总部位于美国的大型健康福利公司，提供广泛的健康保险产品和相关服务。公司总部位于印第安纳波利斯，2022 年从 Anthem, Inc 更名为 Elevance Health，同时继续以既有的州和国家品牌运营面向消费者的健康计划。Gail Boudreaux 担任首席执行官和总裁，领导公司在综合医疗和福利交付方面的战略重点。</p>
</div><p>Elevance's core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.</p>
<div class="lb-trans"><p>Elevance 的核心业务包括为个人、雇主和政府项目（包括 Medicare 和 Medicaid 管理医疗产品）提供医疗和专业健康计划。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than Elevance Health</li>
<li>Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!</li>
<li>How a Family Trust May Be Able To Help Preserve Your Wealth</li>
<li>Do not delete, read immediately</li>
<li>A U.S. “birthright” claim worth trillions - activated quietly</li>
<li>Executive Order 14330: Trump’s Biggest Yet</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Elevance Health</li>
<li>Elon 正在将 SpaceX 上市！$100 的 IPO 前机会！</li>
<li>家族信托如何帮助保护您的财富</li>
<li>请勿删除，立即阅读</li>
<li>美国 “出生权” 索赔价值数万亿 - 静悄悄地激活</li>
<li>执行命令 14330：特朗普迄今为止最大的一次</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding ELV?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Elevance Health, Inc. (NYSE:ELV - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对冲基金持有的 ELV 吗？</strong> 访问 HoldingsChannel.com 获取 Elevance Health, Inc. (NYSE:ELV - 免费报告) 的最新 13F 文件和内部交易。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUVMVg" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=ELV"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Elevance Health Right Now?</h2>
<div class="lb-trans"><h2>您现在应该投资 1,000 美元在 Elevance Health 吗？</h2>
</div><p>Before you consider Elevance Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在您考虑 Elevance Health 之前，您需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Elevance Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及他们推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Elevance Health 并不在名单上。</p>
</div><p>While Elevance Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Elevance Health 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Vest Financial LLC 减少了其在 Elevance Health, Inc. $ELV 的持仓